New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights

Despite the crucial role of CDK2 in tumorigenesis, few inhibitors reached clinical trials for managing lung cancer, the leading cause of cancer death. Herein, we report combinatorial stereoselective synthesis of rationally designed spiroindeno[1,2-b]quinoxaline-based CDK2 inhibitors for NSCLC therap...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M. Abu-Serie, Luis R. Domingo, Sajda Ashraf, Zaheer Ul-Haq, Mohamed S. Nafie, Mohamed Teleb
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2023-12-01
Serie:	Journal of Enzyme Inhibition and Medicinal Chemistry
Soggetti:	Spiro-indeno[12-b]quinoxalines Molecular Electron Density Theory Lung Cancer CDK2 Molecular dynamics
Accesso online:	https://www.tandfonline.com/doi/10.1080/14756366.2023.2281260
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!